Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

EBSEBS
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in EMERGENT BIOSOLUTIONS INC

Yes. Goldman Sachs holds 1,035,421 shares of EBS (Emergent Biosolutions), worth $8.7M, as of its Q2 2026 13F filing. It increased the position by 223,861 shares (+27.6%) from Q1 2026. Goldman Sachs has held EBS in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$8.7M

Current Shares

1M

Total Value Change

+$4.9M

Total Shares Change

+587,573

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+27.6%
$8.7M0.0%$8.38
34
2026-Q1
Increased
811,560
+9.7%
$6.7M0.0%$8.30
30
2025-Q4
Increased
740,100
+19.2%
$9.1M0.0%$12.36
33
2025-Q3
Increased
620,977
+7.2%
$5.5M0.0%$8.82
29
2025-Q2
Decreased
579,392
-46.9%
$3.7M0.0%$6.38
0
2025-Q1
Increased
1.1M
+12.6%
$5.3M0.0%$4.86
30
2024-Q4
Increased
969,072
+116.4%
$9.3M0.0%$9.56
45
2024-Q3
Decreased
447,848
-26.7%
$3.7M0.0%$8.35
0

Other major holders of EBS: Neuberger Berman Group LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used